Elevated Plasma Homocysteine Concentration in Opium-Addicted Individuals

Publish Year: 1394
نوع سند: مقاله ژورنالی
زبان: English
View: 51

This Paper With 8 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_AHJK-7-3_008

تاریخ نمایه سازی: 12 مرداد 1403

Abstract:

Background: Although the triggering role of both opium use and elevated plasma homocysteine level for progressing atherosclerosis and, therefore, appearing coronary heart disease has been clearly determined, no study are available with respect to the relation between these to risk profiles. In the present study and for the first time, we hypothesized that the opium addiction can be potentially correlated with elevated homocysteine concentration. Methods: ۲۱۷ persons (۱۰۳ opium-addicted and ۱۱۴ non-addicted) were randomly selected from the Kerman Coronary Artery Disease Risk Study (KERCADRS), Iran, as a population-based, epidemiological prospective study. In all participants, an enzyme immunoassay kit was used to measure homocysteine in serum samples. Findings: The serum level of homocysteine was significantly higher in the opium-addicted ones compared to non-addicted individuals (۱۱.۴۹ ± ۷.۴۵ vs. ۸.۰۲ ± ۳.۸۷ μmol/l) (P < ۰.۰۰۱). In this regard, ۲۱.۳% of the opium users and only ۳.۲% of the non-users had homocysteine concentration > ۱۵ μmol/l (P < ۰.۰۰۱). On the other hand, individuals addicted to opiates exhibited significantly elevated odds of having homocysteine level higher than ۱۵ [odds ratio (OR) = ۸.۲۴۴, ۹۵% confidence interval (CI) = ۳.۱۱۷-۲۱.۸۰۶]. Multivariable linear regression model showed that the opium addiction could strongly predict elevated homocysteine level in the study individuals [beta = ۳.۵۲۴, standard error (SE) = ۰.۸۵۲] (P < ۰.۰۰۱). Conclusion: Opium consumption can be strongly accompanied with the elevation of plasma homocysteine concentration, and thus opium addiction can exhibit elevated odds of having hyperhomocysteinemia.

Authors

Mohammad Masoomi

‎Associate Professor, Physiology Research Center, Institute of Basic and Clinical ‎Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran‎

Nahid Azdaki

Resident, Atherosclerosis and Coronary Artery Research Center, Brjand University of Medical Sciences, Birjand, Iran

Beydolah Shahouzehi

‎PhD Student, Physiology Research Center, Institute of Neuropharmacology, Kerman ‎University of Medical Sciences, Kerman, Iran